The Center for Artificial Intelligence and Quantum Computing in System Brain Research (CLARA) represents a paradigm shift in neurodegenerative disease research. Our innovative approach combines cutting-edge artificial intelligence/machine learning, quantum computing, and high-performance computing to tackle the complex challenges of brain disorders, particularly Alzheimer's disease.
CLARA's research strategy is built on three interconnected pillars:
We develop advanced foundation models to simulate protein dynamics and aggregation involved in neurodegenerative diseases. By harnessing quantum computing power, we can explore molecular mechanisms at unprecedented scales, opening new avenues for drug discovery.
Our team creates generative AI models that integrate diverse data types, from molecular to clinical, to understand the complex progression of Alzheimer's disease over decades. This approach aims to revolutionize patient care through precision medicine tools.
We are building a first-of-its-kind integrated knowledge platform that allows exploration across various spatial and temporal levels of brain organization. This innovative tool will provide crucial insights into the intricate connections between biological factors and clinical symptoms.
By combining these research streams with our state-of-the-art CLARA Testbed infrastructure, we are uniquely positioned to:
Accelerate the discovery of new intervention targets for neurodegenerative diseases
Develop more accurate predictive models for disease progression
Identify personalized therapeutic approaches for patients
Bridge the gap between molecular processes and clinical outcomes
Our interdisciplinary team of experts from neuroscience, artificial intelligence, quantum computing, and clinical research is committed to pushing the boundaries of brain research. Together, we aim to unravel the mysteries of neuronal longevity and vitality, paving the way for groundbreaking advancements in the fight against neurodegenerative diseases.